Showing 1 - 20 results of 70 for search '"Заболевания периферических артерий"', query time: 0.71s Refine Results
  1. 1
  2. 2
    Academic Journal

    Contributors: Authors declare no research funding., Авторы заявляют об отсутствии финансирования исследования.

    Source: Complex Issues of Cardiovascular Diseases; Том 14, № 2 (2025); 146-154 ; Комплексные проблемы сердечно-сосудистых заболеваний; Том 14, № 2 (2025); 146-154 ; 2587-9537 ; 2306-1278

    File Description: application/pdf

    Relation: https://www.nii-kpssz.com/jour/article/view/1449/1026; Rümenapf G., Morbach S., Schmidt A., Sigl M. Intermittent Claudication and Asymptomatic Peripheral Arterial Disease. Dtsch Arztebl Int. 2020;117(11):188-193. doi:10.3238/arztebl.2020.0188; Sumin A.N., Medvedeva Yu.D., Shcheglova A.V., Ivanov S.V., Barbarash L.S. Outpatient management of patients with peripheral artery disease by cardiologists or surgeons: influence on the prognosis and prevalence of surgical interventions. Complex Issues of Cardiovascular Diseases. 2023;12(1):142-150. doi:10.17802/2306-1278-2023-12-1-142-150; Novakovic M., Jug B., Lenasi H. Clinical impact of exercise in patients with peripheral arterial disease. Vascular. 2017;25(4):412-422. doi:10.1177/1708538116678752.; Ismail A.M.A., Abdelghany A.I. Effect of Adding a 2-Month Consequent Continuous and Interval Elliptical Aerobic Training to Once-Daily 5-mg Tadalafil Administration on Erectile Dysfunction in Obese Men. Sex Disabil 2022; 40, 129–139. doi:10.1007/s11195-021-09720-0; Ismail A.M.A. Metabolic syndrome components response to the conducted 16-week randomised-controlled training trial on an elliptical trainer. Eur J Physiother. 2023;25:3:147-153. doi:10.1080/21679169.2021.2022756; Rajalekshmi R., Agrawal D.K. Energizing Healing with Electromagnetic Field Therapy in Musculoskeletal Disorders. J Orthop Sports Med. 2024;6(2):89-106. doi:10.26502/josm.511500147; Kim C.H., Wheatley-Guy C.M., Stewart G.M., Yeo D., Shen W.K., Johnson B.D. The impact of pulsed electromagnetic field therapy on blood pressure and circulating nitric oxide levels: a double blind, randomized study in subjects with metabolic syndrome. Blood Press. 2020;29(1):47-54. doi:10.1080/08037051.2019.1649591.; Ingwersen M., Kunstmann I., Oswald C., Best N., Weisser B., Teichgräber U. Exercise Training for Patients With Peripheral Arterial Occlusive Disease. Dtsch Arztebl Int. 2023;120(51-52):879-885. doi:10.3238/arztebl.m2023.0231; Herraiz-Adillo Á., Cavero-Redondo I., Álvarez-Bueno C., Pozuelo-Carrascosa D.P., Solera-Martínez M. The accuracy of toe brachial index and ankle brachial index in the diagnosis of lower limb peripheral arterial disease: A systematic review and meta-analysis. Atherosclerosis. 2020;315:81-92. doi:10.1016/j.atherosclerosis.2020.09.026; Dinesh R., Vinod K.V., Ramkumar G. Comparison of resting/postexercise ankle-brachial index and transcutaneous partial pressure of oxygen for noninvasive diagnosis of peripheral artery disease in type 2 diabetes mellitus. Med J Armed Forces India. 2023;79(2):157-164. doi:10.1016/j.mjafi.2020.11.002; Yang M.C., Huang Y.Y., Hsieh S.H., Sun J.H., Wang C.C., Lin C.H. Ankle-Brachial Index Is Independently Associated With Cardiovascular Outcomes and Foot Ulcers in Asian Patients With Type 2 Diabetes Mellitus [published correction appears in Front Endocrinol (Lausanne). 2022;13:878492. doi:10.3389/fendo.2022.878492.; Golledge J. Update on the pathophysiology and medical treatment of peripheral artery disease. Nat Rev Cardiol. 2022;19(7):456-474. doi:10.1038/s41569-021-00663-9; Poredos P., Boc V., Zlajpah U., Mangaroska A.S., Poredos P. Walking Impairment Questionnaire and Walking Tests are Reliable Indicators of Success of Treatment of Peripheral Artery Disease. Angiology. 2022;73(4):331-337. doi:10.1177/00033197211045281; Boylan L., Nesbitt C., Wilson L., Allen J., Sims A., Guri I., Mawson P., Oates C., Stansby G., Investigators OBOTN. Reliability of the Edinburgh Claudication Questionnaire for Identifying Symptomatic PAD in General Practice. Angiology. 2021;72(5):474-479. doi:10.1177/0003319720984882; Parkington T., Broom D., Maden-Wilkinson T., Nawaz S., Klonizakis M. Low-intensity resistance exercise with blood flow restriction for patients with claudication: A randomized controlled feasibility trial. Vasc Med. 2023;28(6):554-563. doi:10.1177/1358863X231200250; Ali Ismail A., Shaaban Abd El-Azeim A. Immediate fasting blood glucose response to electroacupuncture of ST36 versus CV 12 in patients with type 2 diabetes mellitus: randomized controlled trial. Fam Med Prim Care Rev. 2021;23(4):437-441. doi:10.5114/fmpcr.2022.110370.; Ali Ismail A. Virtual-reality rehabilitation for inpatient elderly leukemic patients: psychological and physical roles during the fourth COVID-19 wave. Fam Med Prim Care Rev. 2022;24(2):185-186. doi:10.5114/fmpcr.2022.115882.; Novaković M., Krevel B., Rajkovič U., Vižintin Cuderman T., Janša Trontelj K., Fras Z., Jug B. Moderate-pain versus pain-free exercise, walking capacity, and cardiovascular health in patients with peripheral artery disease. J Vasc Surg. 2019;70(1):148-156. doi:10.1016/j.jvs.2018.10.109; Guerriero F., Botarelli E., Mele G., Polo L., Zoncu D., Renati P., Sgarlata C., Rollone M., Ricevuti G., Maurizi N., Francis M., Rondanelli M., Perna S., Guido D, Mannu P. Effectivness of an innovative pulsed electromagnetic field stimulation in healing of untreatable skin ulcers in the frail elderly: two case reports. Case Rep Dermatol Med. 2015:1-6. doi:10.1155/2015/576580; Marković M.D., Marković D.M., Dragaš M.V., Končar I.B., Banzić I.L., Ille M.E., Davidović L.B. The role of kinesitherapy and electrotherapeutic procedures in non-operative management of patients with intermittent claudications. Vascular. 2016;24(3):246-253. doi:10.1177/1708538115593651; Giusti A., Giovale M., Ponte M., Fratoni F., Tortorolo U., De Vincentiis A., Bianchi G. Short-term effect of low-intensity, pulsed, electromagnetic fields on gait characteristics in older adults with low bone mineral density: a pilot randomized-controlled trial. Geriatr Gerontol Int. 2013;13(2):393-397. doi:10.1111/j.1447-0594.2012.00915.x; Stewart G.M., Wheatley-Guy C.M., Johnson B.D., Shen W.K., Kim C.H. Impact of pulsed electromagnetic field therapy on vascular function and blood pressure in hypertensive individuals. J Clin Hypertens (Greenwich). 2020;22(6):1083-1089. doi:10.1111/jch.13877; Bragin D.E., Statom G.L., Hagberg S., Nemoto E. Increases in microvascular perfusion and tissue oxygenation via pulsed electromagnetic fields in the healthy rat brain. J Neurosurg. 2015;122(5):1239-1247. doi:10.3171/2014.8.JNS132083; Deng H., Liu L., Tang X., Lu Y., Wang X., Zhao Y., Shi Y. Impact of specific electromagnetic radiation on wakefulness in mice. Proc Natl Acad Sci USA. 2024;121(15):e2313903121. doi:10.1073/pnas.2313903121; Pan Y., Dong Y., Hou W., Ji Z., Zhi K., Yin Z., Wen H., Chen Y. Effects of PEMF on microcirculation and angiogenesis in a model of acute hindlimb ischemia in diabetic rats. Bioelectromagnetics. 2013;34(3):180-188. doi:10.1002/bem.21755.

  3. 3
  4. 4
  5. 5
  6. 6
    Academic Journal

    Contributors: Работа выполнена при поддержке комплексной программы фундаментальных исследований СО РАН в рамках темы фундаментальных исследований НИИ комплексных проблем сердечно-сосудистых заболеваний № 0419-2022-0002 «Разработка инновационных моделей управления риска развития заболеваний системы кровообращения с учетом коморбидности на основе изучения фундаментальных, клинических, эпидемиологических механизмов и организационных технологий оказания медицинской помощи в промышленном регионе Сибири».

    Source: Complex Issues of Cardiovascular Diseases; Том 13, № 1 (2024); 129-137 ; Комплексные проблемы сердечно-сосудистых заболеваний; Том 13, № 1 (2024); 129-137 ; 2587-9537 ; 2306-1278

    File Description: application/pdf

    Relation: https://www.nii-kpssz.com/jour/article/view/1460/885; Барбараш Л.С., Сумин А.Н., Безденежных А.В., Жучкова Е.А., Барбараш О.Л. Распространенность мультифокального атеросклероза у больных с ишемической болезнью сердца. Комплексные проблемы сердечно-сосудистых заболеваний. 2013;(3):4-11. doi:10.17802/2306-1278-2013-3-4-11; Иванов С.В., Сумин А.Н., Казачек Я.В., Филипьев Д.Е., Гусев С.М., Малышенко Е.С., Барбараш Л.С. Пути оптимизации результатов реваскуляризации у пациентов с мультифокальным атеросклерозом. Комплексные проблемы сердечно-сосудистых заболеваний. 2013;(3):26-35. doi:10.17802/2306-1278-2013-3-26-35; Sumin A.N., Shcheglova A.V., Ivanov S.V., Barbarash O.L. Long-Term Prognosis after Coronary Artery Bypass Grafting: The Impact of Arterial Stiffness and Multifocal Atherosclerosis. J Clin Med. 2022;11(15):4585. doi:10.3390/jcm11154585.; Smilowitz N.R., Cornwell M., Offerman E.J., Rockman C.B., Shah S.H., Newman J.D., Ruggles K., Voora D., Berger J.S. Risk factors, transcriptomics, and outcomes of myocardial injury following lower extremity revascularization. Sci Rep. 2022;12(1):6718. doi:10.1038/s41598-022-10241-9.; Fowkes F.G., Rudan D., Rudan I., Aboyans V., Denenberg J.O., McDermott M.M., Norman P.E., Sampson U.K., Williams L.J., Mensah G.A., Criqui M.H. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382(9901):1329-40. doi:10.1016/S0140-6736(13)61249-0.; Evans P., Sobieszczyk P., Eisenhauer A.C., Ostrowski S., Todoran T.M., Kinlay S. Risk of Mortality Related to Recurrent Limb Events After Endovascular Revascularization of the Superficial Femoral Artery for Peripheral Artery Disease: The Boston Femoral Artery Endovascular Revascularization Outcomes (Boston FAROUT) Study. Am J Cardiol. 2023;205:425-430. doi:10.1016/j.amjcard.2023.07.172.; Boyd S., Dittman J.M., Tse W., Lavingia K.S., Amendola M.F. Modern Lower Extremity Bypass Outcomes by Anesthesia Type in the Veteran Population. Ann Vasc Surg. 2022;80:187-195. doi:10.1016/j.avsg.2021.08.028.; He J.J., Horns J.J., Kraiss L.W., Smith B.K., Griffin C.L., DeMartino R.R., Sarfati M.R., Brooke B.S. High-intensity statin therapy reduces risk of amputation and reintervention among patients undergoing lower extremity bypass for chronic limb-threatening ischemia. J Vasc Surg. 2023;77(2):497-505. doi:10.1016/j.jvs.2022.09.007.; Cai M., Xie Y., Bowe B., Gibson A.K., Zayed M.A., Li T., Al-Aly Z. Temporal Trends in Incidence Rates of Lower Extremity Amputation and Associated Risk Factors Among Patients Using Veterans Health Administration Services From 2008 to 2018. JAMA Netw Open. 2021;4(1):e2033953. doi:10.1001/jamanetworkopen.2020.33953.; Aboyans V., Ricco J.B., Bartelink M.E.L., Björck M., Brodmann M., Cohnert T., Collet J.P., Czerny M., De Carlo M., Debus S., Espinola-Klein C., Kahan T., Kownator S., Mazzolai L., Naylor A.R., Roffi M., Röther J., Sprynger M., Tendera M., Tepe G., Venermo M., Vlachopoulos C., Desormais I.; ESC Scientific Document Group. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018;39(9):763-816. doi:10.1093/eurheartj/ehx095.; Saxon J.T., Safley D.M., Mena-Hurtado C., Heyligers J., Fitridge R., Shishehbor M., Spertus J.A., Gosch K., Patel M.R., Smolderen K.G. Adherence to Guideline-Recommended Therapy-Including Supervised Exercise Therapy Referral-Across Peripheral Artery Disease Specialty Clinics: Insights From the International PORTRAIT Registry. J Am Heart Assoc. 2020;9(3):e012541. doi:10.1161/JAHA.119.012541.; Hua S., Isasi C.R., Kizer J.R., Matsushita K., Allison M.A., Tarraf W., Qi Q., Ponce S.G., Daviglus M., Kaplan R.C. Underuse of Cardiovascular Medications in Individuals With Known Lower Extremity Peripheral Artery Disease: HCHS/SOL. J Am Heart Assoc. 2020;9(16):e015451. doi:10.1161/JAHA.119.015451.; Барбараш Л.С., Сумин А.Н., Медведева Ю.Д., Корок Е.В. Сравнительное исследование результатов трехлетнего наблюдения у кардиологов и хирургов пациентов с облитерирующим атеросклерозом нижних конечностей. Рациональная Фармакотерапия в Кардиологии 2019;15(5):690-696. doi:10.20996/1819-6446-2019-15-5-690-696; Kumbhani D.J., Steg P.G., Cannon C.P., Eagle K.A., Smith S.C.Jr., Goto S., Ohman E.M., Elbez Y., Sritara P., Baumgartner I., Banerjee S., Creager M.A., Bhatt D.L.; REACH Registry Investigators. Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry. Eur Heart J. 2014;35(41):2864-72. doi:10.1093/eurheartj/ehu080.; Lo H.Y., Lin Y.S., Lin D.S., Lee J.K., Chen W.J. Association of Statin Therapy With Major Adverse Cardiovascular and Limb Outcomes in Patients With End-stage Kidney Disease and Peripheral Artery Disease Receiving Maintenance Dialysis. JAMA Netw Open. 2022;5(9):e2229706. doi:10.1001/jamanetworkopen.2022.29706.; Kim G.S., Seo J., Kim B.G., Jin M.N., Lee H.Y., Kim B.O., Byun Y.S. Impact of Statin Treatment Intensity after Endovascular Revascularization on Lower Extremity Peripheral Artery Disease. Yonsei Med J. 2022;63(4):333-341. doi:10.3349/ymj.2022.63.4.333.; Navar A.M., Kolkailah A.A., Gupta A., Gillard K.K., Israel M.K., Wang Y., Peterson E.D. Gaps in Guideline-Based Lipid-Lowering Therapy for Secondary Prevention in the United States: A Retrospective Cohort Study of 322 153 Patients. Circ Cardiovasc Qual Outcomes. 2023;16(8):533-543. doi:10.1161/CIRCOUTCOMES.122.009787.; Belur A.D., Shah A.J., Virani S.S., Vorla M., Kalra D.K. Role of Lipid-Lowering Therapy in Peripheral Artery Disease. J Clin Med. 2022;11(16):4872. doi:10.3390/jcm11164872.; Wittig T., Pflug T., Schmidt A., Scheinert D., Steiner S. Impact of Optimal Medical Therapy on Reintervention and Survival Rates after Endovascular Infrapopliteal Revascularization. J Clin Med. 2023;12(15):5146. doi:10.3390/jcm12155146.; Сумин А.Н., Медведева Ю.Д., Щеглова А.В., Барбараш Л.С. Пути снижения риска прогрессирования атеросклероза артерий нижних конечностей с позиции кардиолога. Комплексные проблемы сердечно-сосудистых заболеваний.2021;10(1):55-64. doi.10.17802/2306-1278-2021-10-1-55-64.; Thiney M., Della Schiava N., Feugier P., Lermusiaux P., Ninet J., Millon A., Long A. How Admission to a Vascular Surgery Department Improves Medical Treatment in Patients with Lower Extremity Peripheral Arterial Disease. Ann Vasc Surg. 2017;40:85-93. doi:10.1016/j.avsg.2016.08.030.; Howard R., Albright J., Powell C., Osborne N., Corriere M., Laveroni E., Sukul D., Goodney P., Henke P. Underutilization of medical management of peripheral artery disease among patients with claudication undergoing lower extremity bypass. J Vasc Surg. 2022;76(4):1037-1044.e2. doi:10.1016/j.jvs.2022.05.016.

  7. 7
    Academic Journal
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
    Academic Journal

    Contributors: Авторы заявляют об отсутствии финансирования исследования.

    Source: Complex Issues of Cardiovascular Diseases; Том 12, № 2 (2023); 6-13 ; Комплексные проблемы сердечно-сосудистых заболеваний; Том 12, № 2 (2023); 6-13 ; 2587-9537 ; 2306-1278

    File Description: application/pdf

    Relation: https://www.nii-kpssz.com/jour/article/view/1259/783; https://www.nii-kpssz.com/jour/article/downloadSuppFile/1259/1269; https://www.nii-kpssz.com/jour/article/downloadSuppFile/1259/1270; https://www.nii-kpssz.com/jour/article/downloadSuppFile/1259/1271; https://www.nii-kpssz.com/jour/article/downloadSuppFile/1259/1272; Бокерия Л.А., Голухова Е.З. Клиническая кардиология: диагностика и лечение. В 3 т. Москва: изд-во НЦССХ им. А.Н. Бакулева; 2011. 662 с.; Meyrier A. Athérosclérose et reins [Atherosclerosis and the kidney]. Nephrol Ther. 2005;1(3):183-202. French. doi:10.1016/j.nephro.2005.06.006.; Beita A.K.V., Whayne T.F. The Superior Mesenteric Artery: From Syndrome in the Young to Vascular Atherosclerosis in the Old. Cardiovasc Hematol Agents Med Chem. 2019;17(2):74-81. doi:10.2174/1871525717666190920100518.; Ohman E.M., Bhatt D.L., Steg P.G., Goto S., Hirsch A.T., Liau C.S., Mas J.L., Richard A.J., Röther J., Wilson P.W.; REACH Registry Investigators. The REduction of Atherothrombosis for Continued Health (REACH) Registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design. Am Heart J. 2006;151(4):786. doi:10.1016/j.ahj.2005.11.004.; Прудников А.Р., Щупакова А.Н. Мультифокальный атеросклероз - один из главных факторов риска, ускоряющий развитие острых сердечно-сосудистых событий. Медицинский академический журнал. 2018;18(2):29-42. doi:10.17816/MAJ18229-42.; Steffel J., Eikelboom J.W., Anand S.S., Shestakovska O., Yusuf S., Fox K.A.A. The COMPASS Trial: Net Clinical Benefit of Low-Dose Rivaroxaban Plus Aspirin as Compared With Aspirin in Patients With Chronic Vascular Disease. Circulation. 2020;142(1):40-48. doi:10.1161/CIRCULATIONAHA.120.046048.; Fox K.A.A., Anand S.S., Aboyans V., Cowie M.R., Debus E.S., Zeymer U., Monje D., Vogtländer K., Lawatscheck R., Gay A. Xarelto plus Acetylsalicylic acid: Treatment patterns and Outcomes in patients with Atherosclerosis (XATOA): Rationale and design of a prospective registry study to assess rivaroxaban 2.5 mg twice daily plus aspirin for prevention of atherothrombotic events in coronary artery disease, peripheral artery disease, or both. Am Heart J. 2020;222:166-173. doi:10.1016/j.ahj.2020.01.015.; Fox K.A.A., Aboyans V., Debus E.S., Zeymer U., Cowie M.R., Patel M., Welsh R.C., Bosch J., Gay A., Vogtländer K., Anand S.S. Patients selected for dual pathway inhibition in clinical practice have similar characteristics and outcomes to those included in the COMPASS randomized trial: The XATOA Registry. Eur Heart J Cardiovasc Pharmacother. 2022:pvac028. doi:10.1093/ehjcvp/pvac028.; Fowkes F.G., Low L.P., Tuta S., Kozak J.; AGATHA Investigators. Ankle-brachial index and extent of atherothrombosis in 8891 patients with or at risk of vascular disease: results of the international AGATHA study. Eur Heart J. 2006;27(15):1861-7. doi:10.1093/eurheartj/ehl114.; Bhatt D.L., Peterson E.D., Harrington R.A., Ou F.S., Cannon C.F., Gibson C.M., Kleiman N.S., Brindis R.G., Peacock W.F., Brener S.J., Menon V., Smith S.C., Pollack C.V. Jr, Gibler W.B., Ohman E.M., Roe M.T.; CRUSADE Investigators. Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes. Eur Heart J. 2009;30(10):1195-202. doi:10.1093/eurheartj/ehp099.; Сумин А.Н., Корок Е.В., Гайфулин Р.А., Безденежных А.В., Иванов С.В., Барбараш О.Л. Гендерные особенности распространенности и клинических проявлений мультифокального атеросклероза. Клиническая медицина. 2014;1:34–40.; Сумин А.Н., Гайфулин Р.А., Безденежных А.В., Моськин М.Г., Корок Е.В., Карпович А.В., Иванов С.В., Барбараш О.Л., Барбараш Л.С. Распространенность мультифокального атеросклероза в различных возрастных группах. Кардиология. 2012;52(6):28–34.; Муромцева Г.А., Концевая А.В., Константинов В.В., Артамонова Г.В., Гатагонова Т.М., Дупляков Д.В., Ефанов А.Ю., Жернакова Ю.В., Ильин В.А., Конради А.О., Либис Р.А., Минаков Э.В., Недогода С.В., Ощепкова Е.В., Романчук С.В., Ротарь О.П., Трубачева И.А., Деев А.Д., Шальнова С.А., Чазова И.Е., Шляхто Е.В., Бойцов С.А., Баланова Ю.А., Гомыранова Н.В., Евстифеева С.Е., Капустина А.В., Литинская О.А., Мамедов М.Н., Метельская В.А., Оганов Р.Г., Суворова Е.И., Худяков М.Б., Баранова Е.И., Касимов Р.А., Шабунова А.А., Ледяева А.А., Чумачек Е.В., Азарин О.Г., Бабенко Н.И., Бондарцов Л.В., Фурменко Г.И., Хвостикова А.Е., Белова О.А., Назарова О.А., Шутемова Е.А., Барбараш О.Л., Данильченко Я.В., Индукаева Е.В., Максимов С.А., Мулерова Т.А., Скрипченко А.Е., Черкасс Н.В., Басырова И.Р., Исаева Е.Н., Кондратенко В.Ю., Лопина Е.А., Сафонова Д.В., Гудкова С.А., Черепанова Н.А., Кавешников В.С., Карпов Р.С., Серебрякова В.Н., Медведева И.В., Сторожок М.А., Шава В.П., Шалаев С.В., Гутнова С.К., Толпаров Г.В. Распространенность факторов риска неинфекционных заболеваний в российской популяции в 2012-2013 гг. Результаты исследования ЭССЕ-РФ. Кардиоваскулярная терапия и профилактика. 2014;13(6):4-11. doi:10.15829/1728-8800-2014-6-4-11.

  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20